Second Covid-19 Vaccine Candidate
- All
- News
-
"7 More Vaccines In Trials, Some In Advanced Phases": Health Minister
There are seven more COVID-19 vaccine candidates in various stages of clinical trials, and a further two dozen in pre-clinical trials, Union Health Minister Dr Harsh Vardhan said Tuesday afternoon, as he and his wife got their second dose of Covaxin
-
Russia's Second Vaccine "100% Effective" In Early-Stage Trials: Report
A candidate COVID-19 vaccine known as EpiVacCorona, Russia's second to be registered, proved "100% effective" in early-stage trials, Russian consumer health watchdog Rospotrebnadzor has told local media.
-
US Buys 100 Million Additional Doses Of Moderna Covid Vaccine: Health Department
The US said Friday it was purchasing 100 million more doses of the Covid-19 vaccine candidate developed by Moderna, amid reports the government passed on the opportunity to secure more supply of the Pfizer jab.
-
Human Trials Of Second COVID-19 Vaccine Candidate Begin
Indian pharmaceutical giant Zydus Cadila has initiated the phase 1, 2 clinical trial to evaluate the safety and immunogenicity of coronavirus vaccine candidate by intradermal (injection) route in 1,048 subjects after the pharma company got approval from Drugs Controller General of India (DCGI) earlier this month.
-
"7 More Vaccines In Trials, Some In Advanced Phases": Health Minister
There are seven more COVID-19 vaccine candidates in various stages of clinical trials, and a further two dozen in pre-clinical trials, Union Health Minister Dr Harsh Vardhan said Tuesday afternoon, as he and his wife got their second dose of Covaxin
-
Russia's Second Vaccine "100% Effective" In Early-Stage Trials: Report
A candidate COVID-19 vaccine known as EpiVacCorona, Russia's second to be registered, proved "100% effective" in early-stage trials, Russian consumer health watchdog Rospotrebnadzor has told local media.
-
US Buys 100 Million Additional Doses Of Moderna Covid Vaccine: Health Department
The US said Friday it was purchasing 100 million more doses of the Covid-19 vaccine candidate developed by Moderna, amid reports the government passed on the opportunity to secure more supply of the Pfizer jab.
-
Human Trials Of Second COVID-19 Vaccine Candidate Begin
Indian pharmaceutical giant Zydus Cadila has initiated the phase 1, 2 clinical trial to evaluate the safety and immunogenicity of coronavirus vaccine candidate by intradermal (injection) route in 1,048 subjects after the pharma company got approval from Drugs Controller General of India (DCGI) earlier this month.
